News and Announcements
Australia’s voice technology start-up hits the halfway mark for its seed raise
- Published September 02, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Imagine living one day without your voice. This lasts a lifetime for people who suffer permanent voice loss. But thanks to Laronix, there is a modern solution to the problem that affects this population.
Laronix was founded in 2018 with the vision of restoring natural voice for people with voice loss, including laryngectomy patients, who have permanently lost their larynx and subsequently their voice due to cancer. Existing solutions for this population are either extremely invasive or leave the patient with an unnatural-sounding voice. In some cases, the surgery leaves people with no voice and no solution at all. With the second-highest suicide rate among all cancer survivors, laryngectomy patients face challenges on a daily basis, not only with their physical health, but also mental health, employment ability, and feelings of isolation.
Laronix has developed Bionic Voice, the world’s first smart artificial voice-box, to solve the problem of permanent voice loss. Bionic Voice is non-invasive and registered with the FDA and TGA as Class I device. It significantly reduces the risk of infections and other complications seen with existing solutions. Bionic Voice uses natural voice technology to give people their unique voice back, whether male, female, or non-binary. Laronix is now working closely with two major hospitals in Australia and the US for the clinical testing of Bionic Voice and it is on track to launch this product in 2023.
By developing Bionic Voice, Laronix is creating a new global voice technology market worth AU$6.8 billion. As a fast-growing Australian voice technology start-up in the health domain, Laronix has already secured 50% of its AU$2 million seed raise. The Laronix Team continues its journey to solve permanent voice loss not only for laryngectomy patients, but also a broader population of people with voice impairment, such as structural and functional voice disorders. Laronix is excited to share this journey with collaborators and investors who also believe in the vision of bringing natural voice to people with voice loss and impairments.
Company Updates
The $3.5 Trillion Succession Wave: Why 48% of Australian Business Owners Are About to Destroy Value
Australia’s Largest Wealth Transfer Has No Exit Plan Australian business succession planning is broken. An estimated $3.5 trillion in assets will pass from Baby Boomers to younger generations over the next two decades. The numbers reveal a crisis. 48% of Baby Boomer business owners plan to exit within five years. Only 24% have formal succession […]
The Great Life Science Reset: Why the “Sick Care” Model is Failing
The data reveals a significant transition: the end of the traditional sick care model and the rise of a proactive healthcare ecosystem. Learn how smart money is utilising AI to cut drug discovery times in half, transform diagnostics to detect complex diseases in days, and create efficiencies to scale the healthcare system without a proportional increase in costs.
Australia’s A$4 Trillion Generational Pivot
Australia’s wealth management landscape is undergoing a dramatic transformation. For decades, family offices operated quietly during the “Great Moderation”, an era characterised by low volatility, cheap capital, and global economic synchronisation. Today, that stability has given way to fiscal uncertainty, geopolitical tensions, and intensifying regulatory scrutiny. Yet amid this global turbulence, Australia has emerged as […]
Backed By Leading Investment Groups and Family Offices
